News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Poirier Michael S.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2022 |
4
| Poirier Michael S. (Chairman and CEO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 375,000 options to buy
@ $0.5136, valued at
$192.6k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
4
| Poirier Michael S. (Chairman, CEO & President) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Bought 11,005 shares
@ $1.8, valued at
$19.8k
|
|
| 06/08/2020 |
4
| Poirier Michael S. (Chairman, President & CEO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $5.13, valued at
$5.1M
|
|
| 05/27/2020 |
4
| Poirier Michael S. (Chairman, President & CEO.) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Acquired 169,192 shares
@ $0
Acquired 22,142 options to buy
@ $2.0663, valued at
$45.8k
Acquired 29,847 options to buy
@ $2.0663, valued at
$61.7k
Acquired 22,142 options to buy
@ $2.5405, valued at
$56.3k
Acquired 14,437 options to buy
@ $2.5405, valued at
$36.7k
|
|
|
|